Legg-Calvé-Perthes Disease in Yorkshire Terriers: Long-term Hip Health After Treatment

Understanding Legg-Calvé-Perthes disease (avascular necrosis of the femoral head) in Yorkshire Terriers — the most commonly affected breed. Covers diagnosis, surgical outcomes, rehabilitation, and long-term hip health management for aging Yorkies.

By SeniorPetCare Research Published: July 4, 2026 Last updated: August 4, 2026

Quick Answer

Yorkshire Terriers with Legg‑Calvé‑Perthes usually regain good long‑term hip function after timely surgical treatment (commonly femoral head and neck ostectomy; total hip replacement is uncommon). With appropriate rehabilitation, weight management, joint supplements, and periodic veterinary monitoring, most Yorkies return to near‑normal activity, although mild lameness or osteoarthritis may develop with age. Early surgery plus consistent physiotherapy gives the best prognosis.

Article Summary — Key Takeaways

Reading time: 5 minutes | 6 key points

Point 1: Yorkshire Terriers most commonly affected breed for LCPD
Point 2: FHO surgery has 84-100% success rate in small breeds
Point 3: Affects toy breeds during growth period 3-13 months
Point 4: Bilateral involvement in 12-16% of affected dogs
Point 5: Post-surgical dogs achieve good to excellent long-term outcomes
Point 6: Senior Yorkies with LCPD history need annual hip monitoring

Legg-Calvé-Perthes Disease in Yorkshire Terriers

Legg-Calvé-Perthes disease (LCPD), also known as avascular necrosis of the femoral head, is a condition where blood supply to the hip joint's ball (femoral head) is disrupted, causing bone death and joint collapse. Yorkshire Terriers are the most commonly affected breed in long-term treatment outcome studies (UFAW, 2026).

Key Statistics & Research Data

Yorkshire Terriers are the most commonly affected breed in long-term LCPD studies (UFAW, 2026)
Affects toy breeds and small terriers during growth period (3-13 months)
Suspected autosomal recessive inheritance in some breeds
Femoral head ostectomy (FHO) success rate: 84-100% return to functional mobility (Off & Matis, VCOT, 2010)
Bilateral involvement in 12-16% of affected dogs
Without treatment, leads to severe osteoarthritis and chronic pain
Post-FHO, most dogs achieve good to excellent long-term outcomes with proper rehabilitation

Understanding the Disease Process

Pathophysiology

Blood supply to femoral head is disrupted (cause unclear — genetic, hormonal, or vascular)

Bone cells die (avascular necrosis)

Femoral head weakens and collapses

Joint becomes painful and arthritic

Muscle atrophy develops from disuse

Why Yorkshire Terriers?

Small breed predisposition (likely genetic component)
Suspected autosomal recessive inheritance pattern
Single blood vessel supply to femoral head in toy breeds (more vulnerable to disruption)

Diagnosis

| Method | Findings | Timing | |--------|----------|--------| | Physical exam | Pain on hip extension, muscle atrophy | Early | | Radiographs | Femoral head irregularity, collapse | After 2-3 weeks | | CT scan | Detailed bone changes | Surgical planning | | Gait analysis | Lameness severity grading | Monitoring |

Treatment: Femoral Head Ostectomy (FHO)

FHO is the standard surgical treatment for LCPD in small breeds:

Removes the damaged femoral head and neck
Body forms a "false joint" (pseudoarthrosis) from scar tissue
Success rate: 84-100% return to functional mobility
Small breeds like Yorkies have excellent outcomes due to low body weight

Long-term Hip Health for Senior Yorkies Post-LCPD

Yorkshire Terriers who had LCPD treatment as young dogs face specific senior considerations:

Monitoring Needs

Annual hip radiographs to assess pseudoarthrosis
Muscle mass assessment (affected vs. unaffected limb)
Gait analysis for compensatory changes
Contralateral hip monitoring (12-16% bilateral risk)

Maintaining Mobility

Regular low-impact exercise (walking, swimming)
Weight management (reduces stress on pseudoarthrosis)
Joint supplements (omega-3s, glucosamine)
Physical therapy for muscle maintenance
Warm-up before activity

When Arthritis Develops

NSAIDs with regular renal/hepatic monitoring
Gabapentin for chronic pain
Laser therapy
Acupuncture
Environmental modifications (ramps, orthopedic beds)

Key Takeaways

Yorkshire Terriers are the most commonly affected breed for Legg-Calvé-Perthes disease
FHO surgery has 84-100% success rate in small breeds
Post-surgical dogs can live full, active lives with proper rehabilitation
Senior Yorkies with LCPD history need annual hip monitoring
Weight management and regular exercise maintain pseudoarthrosis function
Bilateral involvement occurs in 12-16% of cases

Frequently Asked Questions

What is the long-term prognosis for Yorkshire Terriers with Legg-Calvé-Perthes disease?

The long-term prognosis is generally excellent. Femoral head ostectomy (FHO) — the standard surgical treatment — has an 84-100% success rate for returning small breeds to functional mobility. Yorkshire Terriers do particularly well due to their low body weight. Post-surgical dogs can live full, active lives with proper rehabilitation. However, they need lifelong monitoring for compensatory joint issues and should maintain lean body weight to protect the pseudoarthrosis.

Is Legg-Calvé-Perthes disease hereditary in Yorkshire Terriers?

Yes, there is strong evidence for a hereditary component. LCPD is suspected to follow an autosomal recessive inheritance pattern in some breeds, and Yorkshire Terriers are the most commonly affected breed. Responsible breeding programs should screen for this condition. If your Yorkie has been diagnosed, their relatives may carry the gene. The condition typically manifests during the growth period (3-13 months of age) and bilateral involvement occurs in 12-16% of cases.

Tracheal Collapse in Senior Yorkshire Terriers: Understanding and Managing This Breed-Defining Condition (yorkshire-terrier) — Senior Yorkshire Terriers commonly develop tracheal collapse, graded I–IV by degree of airway narrowing. Recognize a harsh “honking” cough, exercise intolerance, cyanosis or syncope. Medical management includes weight loss, harness use, cough suppressants, bronchodilators, and anti-inflammatories; humidification and smoke avoidance help. Severe or intrathoracic disease may require extraluminal rings or endoluminal stents, each with specific risks and follow-up needs.
Portosystemic Shunt (PSS) in Yorkshire Terriers: Long-term Liver Health Management (yorkshire-terrier) — Yorkshire Terriers with portosystemic shunts fare best with surgical attenuation when feasible; medical management (dietary protein restriction, lactulose, hepatoprotectants such as SAMe and milk thistle, and intermittent antibiotics) provides palliative control. Long‑term care requires lifelong monitoring (pre‑ and postprandial bile acids, liver enzymes, CBC), weight management, senior‑appropriate hepatic diets, and regular veterinary reassessment to detect complications and optimize prognosis.
Patellar Luxation in Senior Yorkshire Terriers: Grading, Management, and Long-term Joint Health (yorkshire-terrier) — Patellar luxation in senior Yorkshire Terriers is graded I–IV. Mild (I–II) or medically high‑risk seniors often respond to conservative care: weight control, NSAIDs, omega‑3s and chondroprotectants, physical therapy, and assistive devices. Surgical correction is recommended for persistent lameness or Grade III–IV instability but weigh anesthetic risk. Regular orthopedic rechecks, radiographs, and early arthritis management preserve mobility and long‑term joint function.
Periodontal Disease in Senior Yorkshire Terriers: Why Dental Health is Critical for Aging Yorkies (yorkshire-terrier) — Periodontal disease affects about 21.1% of Yorkshire Terriers and is the leading health problem in senior Yorkies; untreated it causes pain, tooth loss and can spread bacteria systemically (heart, kidneys). Prevention for aging Yorkies includes daily toothbrushing, veterinary dental cleanings under anesthesia, appropriate dental diets/chews, and biannual oral exams to detect disease early and protect overall health.
Hypoglycemia in Senior Yorkshire Terriers: Prevention, Recognition, and Emergency Response (yorkshire-terrier) — Senior Yorkshire Terriers are prone to hypoglycemia—prevent with frequent small meals (3–4/day), high‑quality protein and complex carbohydrates, regular weight monitoring, and prompt treatment of illness. Watch for weakness, tremors, disorientation, collapse, seizures, or drooling. In an emergency give 1–2 teaspoons of Karo syrup or glucose gel orally if conscious; if unconscious, seek immediate veterinary care and avoid oral administration.
Heart Disease in Senior Yorkshire Terriers: Mitral Valve Disease Screening and Management (yorkshire-terrier) — Mitral valve disease is common in senior Yorkshire Terriers; routine auscultation and annual cardiac exams including echocardiography and chest radiographs help detect early murmur and stage disease. Management includes pimobendan, ACE inhibitors, diuretics as indicated, plus weight control, low sodium diet, exercise moderation, and regular rechecks to optimize quality of life. Early detection improves prognosis and treatment timing.

Explore more: Complete Senior yorkshire-terrier Health Guide | Free AI Health Assessment